Accurate, sensitive mass techniques required to identify specific peak of certain nitrosamines
Continuing its investigation into the presence of potential carcinogenic materials in various medicines, on May 28, the US FDA…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ranitidine
Carcinogens under the scan
As trace amounts of cancer causing contaminants continue to crop up in certain medicines, pharma companies are upgrading their…
Why API price needs to be part of NPPA’s pricing formula
The over-dependence on China and other countries imperils not just the health of the pharma industry in India, but also that of…
Glenmark recalls over two lakh cartons of product in US
According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), Glenmark Pharmaceuticals Inc USA is…
After sartans and ranitidine, where will NDMA show up next?
While regulators and pharma companies try to understand if it is the product or the process that is at fault in the ranitidine…
Dr Reddy’s recalls all its ranitidine products in US
The recall started on October 1 after USFDA found the presence of NDMA in certain ranitidine products above the permissable levels…
Teva’s UK arm recalls some batches of Ranitidine: Medicines watchdog
Teva, the world's largest generic drugmaker, is recalling all unexpired stock of Ranitidine Effervescent Tablets in 150 micrograms…
FDA says new test finds “unacceptable levels” of impurity in heartburn drugs
However, the agency said its testing method found much lower levels of the impurity, N-nitrosodimethylamine (NDMA), than a higher…
Dr Reddy’s halts worldwide supply of ranitidine
USFDA probing into the reported impurity N-nitrosodimethylamine in it at low levels